{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:29:11Z","timestamp":1787027351874,"version":"build-2736575974"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005053","name":"Biomedical Research Network Centre of Bioengineering Biomaterials and Nanomedicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010790","name":"Erasmus Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PRE2020-092326"],"award-info":[{"award-number":["PRE2020-092326"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006301","name":"Center for International Business Education and Research, University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"State Agency of Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mtbio.2026.103397","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:32:09Z","timestamp":1782405129000},"page":"103397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["3D biomimetic microgel platform for multiple myeloma: Approaching tumor microenvironment on cell lines and patient-derived cells"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0811-2632","authenticated-orcid":false,"given":"M. Inmaculada","family":"Garc\u00eda-Briega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"R\u00f3denas-Rochina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8828-6095","authenticated-orcid":false,"given":"Alison","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Vicente-Tom\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maricarmen","family":"Garc\u00eda Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Andreu Lapiedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8808-3423","authenticated-orcid":false,"given":"Lourdes","family":"Cord\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"Sempere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Lu\u00eds","family":"G\u00f3mez Ribelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.103397_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.mtbio.2026.103397_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/cells12030448","article-title":"Novel local \u201cOff-the-Shelf\u201d immunotherapy for the treatment of myeloma bone disease","volume":"12","author":"Charv\u00e1tov\u00e1","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.mtbio.2026.103397_bib3","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.3390\/cancers14133271","article-title":"The route of the malignant plasma cell in its survival niche: exploring \u201cMultiple Myelomas,\u201d","volume":"14","author":"Solimando","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mtbio.2026.103397_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.6004\/jnccn.2016.0046","article-title":"NCCN Guidelines insights: multiple Myeloma, version 3.2016","volume":"14","author":"Anderson","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103397_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrclinonc.2014.200","article-title":"Current treatment landscape for relapsed and\/or refractory multiple myeloma","volume":"12","author":"Dimopoulos","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103397_bib6","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood-2017-05-743203","article-title":"How I treat myeloma with new agents","volume":"130","author":"Moreau","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.mtbio.2026.103397_bib7","first-page":"367","article-title":"New regimens and directions in the management of newly diagnosed multiple myeloma, am","volume":"96","author":"Bal","year":"2021","journal-title":"J. Hematol."},{"key":"10.1016\/j.mtbio.2026.103397_bib8","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.3390\/ijms21165747","article-title":"In vitro modeling of non-solid tumors: how far can tissue engineering go?","volume":"21","author":"Clara-Trujillo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103397_bib9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.mtbio.2026.103397_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112888","article-title":"Patient-derived multiple myeloma 3D models for personalized medicine\u2014are we there yet?","volume":"23","author":"Louren\u00e7o","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103397_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/B978-0-12-374849-2.00013-6","article-title":"Cell culture techniques","author":"Carter","year":"2010","journal-title":"Guide to Research Techniques in Neuroscience"},{"key":"10.1016\/j.mtbio.2026.103397_bib12","first-page":"910","article-title":"2D and 3D cell cultures \u2013 a comparison of different types of cancer cell cultures","volume":"14","author":"Kapa\u0142czy\u0144ska","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.mtbio.2026.103397_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature12627","article-title":"Tumour heterogeneity in the clinic","volume":"501","author":"Bedard","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103397_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103397_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201600505","article-title":"Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read-outs","volume":"12","author":"Santo","year":"2017","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.mtbio.2026.103397_bib16","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3390\/cells10081961","article-title":"A comprehensive review of the genomics of multiple myeloma: evolutionary trajectories, gene expression profiling, and emerging therapeutics","volume":"10","author":"Awada","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mtbio.2026.103397_bib17","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1182\/blood.V128.22.4432.4432","article-title":"Genomic variability in Multiple Myeloma (MM) patients by race: an analysis of the publicly available mmrf commpass study database","volume":"128","author":"Paulus","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103397_bib18","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nbt.2978","article-title":"Modulating the stem cell niche for tissue regeneration","volume":"32","author":"Lane","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mtbio.2026.103397_bib19","series-title":"Luz\u00e1n 5, Murcia","article-title":"Pregrado de Hematolog\u00eda","author":"Moraleda Jim\u00e9nez","year":"2017"},{"key":"10.1016\/j.mtbio.2026.103397_bib20","first-page":"62","article-title":"The extracellular bone marrow microenvironment\u2014A proteomic comparison of constitutive protein release by in vitro cultured osteoblasts and mesenchymal stem cells","volume":"13","author":"Aaseb\u00f8","year":"2020","journal-title":"Cancers 2021"},{"key":"10.1016\/j.mtbio.2026.103397_bib21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/jnci\/djr218","article-title":"Randomized phase II trials: a long-term investment with promising returns","volume":"103","author":"Sharma","year":"2011","journal-title":"JNCI (J. Natl. Cancer Inst.): J. Natl. Cancer Inst."},{"key":"10.1016\/j.mtbio.2026.103397_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.addr.2014.06.004","article-title":"Bioengineering 3D environments for cancer models","volume":"79\u201380","author":"Alemany-Ribes","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2026.103397_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20250107","article-title":"Organoid-based novel technology for antitumor drug screening","volume":"6","author":"Su","year":"2025","journal-title":"View"},{"key":"10.1016\/j.mtbio.2026.103397_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20240469","article-title":"Micro pattern-based 3D cell culture platform: an overview of technologies and applications","volume":"6","author":"Zhu","year":"2026","journal-title":"Exploration"},{"key":"10.1016\/j.mtbio.2026.103397_bib25","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.3324\/haematol.2018.213355","article-title":"Possibilities and limitations of an in vitro three-dimensional bone marrow model for the prediction of clinical responses in patients with relapsed multiple myeloma","volume":"104","author":"Braham","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103397_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-98760-9","article-title":"A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma","volume":"11","author":"Alhallak","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mtbio.2026.103397_bib27","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00432-021-03854-6","article-title":"Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myeloma","volume":"148","author":"Waldschmidt","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.103397_bib28","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.2147\/IJN.S184262","article-title":"Liposomal drug delivery in an in vitro 3D bone marrow model for multiple myeloma","volume":"13","author":"Braham","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.mtbio.2026.103397_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4939-7021-6_13","article-title":"3D-Dynamic culture models of multiple myeloma","volume":"1612","author":"Ferrarini","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103397_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-024-07038-1","article-title":"In vitro models of the crosstalk between multiple myeloma and stromal cells recapitulate the mild NF-\u03baB activation observed in vivo","volume":"15","author":"Colombo","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mtbio.2026.103397_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10112797","article-title":"Protein-functionalized microgel for multiple myeloma cells' 3D culture","volume":"10","author":"Mar\u00edn-Pay\u00e1","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.mtbio.2026.103397_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214243","article-title":"Co-culture of multiple myeloma cell lines and bone marrow mesenchymal stem cells in a 3D microgel environment","volume":"172","author":"Garc\u00eda-Briega","year":"2025","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.mtbio.2026.103397_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ma14237121","article-title":"Biomimetic 3d environment based on microgels as a model for the generation of drug resistance in multiple myeloma","volume":"14","author":"Mar\u00edn-Pay\u00e1","year":"2021","journal-title":"Materials"},{"key":"10.1016\/j.mtbio.2026.103397_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.212749","article-title":"Novel microgel culture system as semi-solid three-dimensional in vitro model for the study of multiple myeloma proliferation and drug resistance","author":"Clara-Trujillo","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.mtbio.2026.103397_bib35","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.3390\/polym14204282","article-title":"Stability of biomimetically functionalised alginate microspheres as 3D support in cell cultures","volume":"14","author":"Garc\u00eda-Briega","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.mtbio.2026.103397_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jcis.2013.04.044","article-title":"Preparation of monodisperse calcium alginate microcapsules via internal gelation in microfluidic-generated double emulsions","volume":"404","author":"Liu","year":"2013","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.mtbio.2026.103397_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.reactfunctpolym.2004.01.002","article-title":"Investigation of swelling\/degradation behaviour of alginate beads crosslinked with Ca2+ and Ba2+ ions","volume":"59","author":"Bajpai","year":"2004","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.mtbio.2026.103397_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9304592","article-title":"The size stability of alginate beads by different ionic crosslinkers","volume":"2017","author":"Huang","year":"2017","journal-title":"Adv. Mater. Sci. Eng."},{"key":"10.1016\/j.mtbio.2026.103397_bib39","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ijbiomac.2018.04.138","article-title":"Characterisation of bare and tannase-loaded calcium alginate beads by microscopic, thermogravimetric, FTIR and XRD analyses","volume":"115","author":"Larosa","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mtbio.2026.103397_bib40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/05704920701829043","article-title":"Fourier transform infrared (FTIR) spectroscopy of biological tissues","volume":"43","author":"Movasaghi","year":"2008","journal-title":"Appl. Spectrosc. Rev."},{"key":"10.1016\/j.mtbio.2026.103397_bib41","doi-asserted-by":"crossref","first-page":"6950","DOI":"10.1016\/j.biomaterials.2005.05.007","article-title":"Physicochemical model of alginate\u2013poly-l-lysine microcapsules defined at the micrometric\/nanometric scale using ATR-FTIR, XPS, and ToF-SIMS","volume":"26","author":"Tam","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2026.103397_bib42","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1021\/acs.biomac.4c00319","article-title":"Preparation and characterization of photo-cross-linkable methacrylated silk fibroin and methacrylated hyaluronic acid composite hydrogels","volume":"25","author":"Amirian","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.mtbio.2026.103397_bib43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ijbiomac.2022.01.029","article-title":"Crosslinkers for polysaccharides and proteins: synthesis conditions, mechanisms, and crosslinking efficiency, a review","volume":"202","author":"Alavarse","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mtbio.2026.103397_bib44","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/molecules22050778","article-title":"Sulfated alginates as heparin analogues: a review of chemical and functional properties","volume":"22","author":"Arlov","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.mtbio.2026.103397_bib45","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.1039\/c2ra20785k","article-title":"Hydrogel based on an alginate-Ca2+\/chondroitin sulfate matrix as a potential colon-specific drug delivery system","volume":"2","author":"Fajardo","year":"2012","journal-title":"RSC Adv."},{"key":"10.1016\/j.mtbio.2026.103397_bib46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaap.2016.03.014","article-title":"Thermal degradation properties of biobased iron alginate film","volume":"119","author":"Liu","year":"2016","journal-title":"J. Anal. Appl. Pyrolysis"},{"key":"10.1016\/j.mtbio.2026.103397_bib47","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.carbpol.2010.03.025","article-title":"Effect of calcium ion (cross-linker) concentration on porosity, surface morphology and thermal colouior of calcium alginates prepared from algae (Undaria pinnatifida)","volume":"81","author":"Pathak","year":"2010","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103397_bib48","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s43018-025-01072-4","article-title":"A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma","volume":"7","author":"Pilcher","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mtbio.2026.103397_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/jcm14020327","article-title":"From biology to clinical practice: the bone marrow microenvironment in multiple myeloma","volume":"14","author":"Fotiou","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.mtbio.2026.103397_bib50","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1182\/blood-2008-07-170464","article-title":"The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor","volume":"113","author":"Sprynski","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.mtbio.2026.103397_bib51","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1002\/eji.1830271232","article-title":"Major role of the soluble interleukin-6\/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines","volume":"27","author":"Gaillard","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.mtbio.2026.103397_bib52","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/1097-0142(19920315)69:6<1373::AID-CNCR2820690612>3.0.CO;2-1","article-title":"Interleukin\u20106 dependence of advanced malignant plasma cell dyscrasias","volume":"69","author":"Zhang","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.mtbio.2026.103397_bib53","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/cncr.11072","article-title":"A review of the cytokine network in multiple myeloma","volume":"97","author":"Lauta","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.mtbio.2026.103397_bib54","doi-asserted-by":"crossref","first-page":"48732","DOI":"10.18632\/oncotarget.8982","article-title":"The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential","volume":"7","author":"Bieghs","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mtbio.2026.103397_bib55","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.18632\/oncotarget.1736","article-title":"Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma","volume":"5","author":"Borsi","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.mtbio.2026.103397_bib56","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13046-022-02522-y","article-title":"Targeting hypoxia in solid and haematological malignancies","volume":"41","author":"Harris","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103397_bib57","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.trsl.2014.12.001","article-title":"Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma","volume":"165","author":"Borsi","year":"2015","journal-title":"Transl. Res."},{"key":"10.1016\/j.mtbio.2026.103397_bib58","doi-asserted-by":"crossref","first-page":"14728","DOI":"10.1074\/jbc.M003965200","article-title":"Hyaluronic acid induces survival and proliferation of human myeloma cells through an Interleukin-6-mediated pathway involving the phosphorylation of retinoblastoma protein","volume":"276","author":"Vincent","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mtbio.2026.103397_bib59","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1111\/febs.12168","article-title":"The heparanase\/syndecan-1 axis in cancer: mechanisms and therapies","volume":"280","author":"Ramani","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.mtbio.2026.103397_bib60","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood-2007-04-082495","article-title":"The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy","volume":"110","author":"Yang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.mtbio.2026.103397_bib61","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.20564","article-title":"Chondroitin sulfate proteoglycan serglycin influences protein cargo loading and functions of tumor-derived exosomes","volume":"8","author":"Purushothaman","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.mtbio.2026.103397_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2026.103397_bib63","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.semcancer.2010.04.003","article-title":"Adhesion molecules\u2014The lifelines of multiple myeloma cells","volume":"20","author":"Katz","year":"2010","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.mtbio.2026.103397_bib64","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/febs.12179","article-title":"Cell-surface serglycin promotes adhesion of myeloma cells to collagen type i and affects the expression of matrix metalloproteinases","volume":"280","author":"Skliris","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.mtbio.2026.103397_bib65","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1182\/blood-2017-07-797050","article-title":"Syndecan-1 promotes Wnt\/\u03b2-catenin signaling in multiple myeloma by presenting Wnts and R-spondins","volume":"131","author":"Ren","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.mtbio.2026.103397_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13287-017-0753-5","article-title":"Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming","volume":"9","author":"Redondo-Castro","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.mtbio.2026.103397_bib67","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1021\/acsbiomaterials.3c00954","article-title":"Poly(ethylene glycol)-based hydrogel microcarriers alter secretory activity of genetically modified mesenchymal stromal cells","volume":"9","author":"Doron","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.mtbio.2026.103397_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-023-03381-w","article-title":"MSCs' conditioned media cytokine and growth factor profiles and their impact on macrophage polarization","volume":"14","author":"Peshkova","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.mtbio.2026.103397_bib69","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1038\/s41375-020-0785-1","article-title":"Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis","volume":"34","author":"Sarin","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.mtbio.2026.103397_bib70","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/jpet.118.247924","article-title":"Network-based analysis of bortezomib pharmacodynamic heterogeneity in multiple myeloma cells","volume":"365","author":"Ramakrishnan","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.mtbio.2026.103397_bib71","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94543","article-title":"Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies","volume":"3","author":"Gonsalves","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.mtbio.2026.103397_bib72","doi-asserted-by":"crossref","first-page":"77326","DOI":"10.18632\/oncotarget.12643","article-title":"A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications","volume":"7","author":"Jakubikova","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mtbio.2026.103397_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.973836","article-title":"Drug resistance in multiple myeloma: soldiers and weapons in the bone marrow niche","volume":"12","author":"Solimando","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2026.103397_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10060206","article-title":"Constitutive activation of STAT3 in myeloma cells cultured in a three-dimensional, reconstructed bone marrow model","volume":"10","author":"Huang","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mtbio.2026.103397_bib75","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3390\/polym14050876","article-title":"The molecular interaction of collagen with cell receptors for biological function","volume":"14","author":"Elango","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.mtbio.2026.103397_bib76","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fimmu.2015.00201","article-title":"Interactions between Hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer","volume":"6","author":"Misra","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103397_bib77","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.semcancer.2008.03.009","article-title":"Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells, Semin","volume":"18","author":"Toole","year":"2008","journal-title":"Cancer Biol."},{"key":"10.1016\/j.mtbio.2026.103397_bib78","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3390\/ijms19102861","article-title":"The role of tumor microenvironment in chemoresistance: 3D extracellular matrices as accomplices","volume":"19","author":"Senthebane","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103397_bib79","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.3390\/cancers13112542","article-title":"Bone marrow mesenchymal stromal cells in multiple myeloma: their role as active contributors to myeloma progression","volume":"13","author":"Maiso","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.mtbio.2026.103397_bib80","doi-asserted-by":"crossref","first-page":"60698","DOI":"10.18632\/oncotarget.10849","article-title":"Microenvironment drug resistance in multiple myeloma: emerging new players","volume":"7","author":"Di Marzo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mtbio.2026.103397_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1155621","article-title":"Metabolic changes underlying drug resistance in the multiple myeloma tumor microenvironment","volume":"13","author":"Matamala Montoya","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2026.103397_bib82","first-page":"1","article-title":"Effects of mesenchymal stem cells from different sources on the biological functions of multiple myeloma cells","volume":"16","author":"Li","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.mtbio.2026.103397_bib83","author":"Davis"},{"key":"10.1016\/j.mtbio.2026.103397_bib84","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4049\/jimmunol.171.1.88","article-title":"Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis","volume":"171","author":"Pham","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.mtbio.2026.103397_bib85","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1517\/14728222.2013.815728","article-title":"Targeting the ubiquitin-proteasome system for cancer therapy","volume":"17","author":"Shen","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.mtbio.2026.103397_bib86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00277-018-3465-8","article-title":"Glucocorticoids in multiple myeloma: past, present, and future","volume":"98","author":"Burwick","year":"2019","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.mtbio.2026.103397_bib87","article-title":"Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies","volume":"1874","author":"Clarisse","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.mtbio.2026.103397_bib88","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3892\/mmr.2013.1394","article-title":"NS-398 enhances the efficacy of bortezomib against RPMI8226 human multiple myeloma cells","volume":"7","author":"Que","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.mtbio.2026.103397_bib89","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1158\/0008-5472.CAN-14-3400","article-title":"Metabolic signature identifies novel targets for drug resistance in multiple myeloma","volume":"75","author":"Maiso","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103397_bib90","doi-asserted-by":"crossref","DOI":"10.1177\/2040620720932686","article-title":"BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib in vitro and in vivo by promoting mitochondrial pathway-mediated cell apoptosis","volume":"11","author":"Li","year":"2020","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.mtbio.2026.103397_bib91","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.18632\/oncotarget.1497","article-title":"Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms","volume":"4","author":"Abdi","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.mtbio.2026.103397_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071686","article-title":"Emerging therapeutic strategies to overcome drug resistance in multiple myeloma","volume":"13","author":"Davis","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mtbio.2026.103397_bib93","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5114\/aoms.2017.64722","article-title":"Cx43 expressed on bone marrow stromal cells plays an essential role in multiple myeloma cell survival and drug resistance","volume":"13","author":"Fu","year":"2017","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.mtbio.2026.103397_bib94","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.biomaterials.2015.09.017","article-title":"3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma","volume":"73","author":"de la Puente","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2026.103397_bib95","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.beha.2010.09.002","article-title":"Immunophenotyping in multiple myeloma and related plasma cell disorders","volume":"23","author":"Kumar","year":"2010","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.mtbio.2026.103397_bib96","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.3390\/jcm11071809","article-title":"Understanding the bioactivity and prognostic implication of commonly used surface antigens in multiple myeloma","volume":"11","author":"Lebel","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.mtbio.2026.103397_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-025-01284-y","article-title":"CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma","volume":"15","author":"Giorgetti","year":"2025","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.mtbio.2026.103397_bib98","first-page":"122","article-title":"Prognostic significance of CD56 expression in patients with multiple myeloma: a meta-analysis","volume":"27","author":"Zhang","year":"2022","journal-title":"Hematology (United Kingdom)"},{"key":"10.1016\/j.mtbio.2026.103397_bib99","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2141.2003.04260.x","article-title":"CD27 is heterogeneously expressed in multiple myeloma: low CD27 expression in patients with high-risk disease","volume":"121","author":"Guikema","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mtbio.2026.103397_bib100","doi-asserted-by":"crossref","DOI":"10.1186\/s12865-025-00719-2","article-title":"Prognostic value of the expression of CD27 and CD117 in newly diagnosed multiple myeloma patients","volume":"26","author":"Si","year":"2025","journal-title":"BMC Immunol."},{"key":"10.1016\/j.mtbio.2026.103397_bib101","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/10428190290012146","article-title":"CD19 expression and growth inhibition of tumours in human multiple myeloma","volume":"43","author":"Ishikawa","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.mtbio.2026.103397_bib102","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cyto.b.21265","article-title":"Immunophenotype of normal vs. myeloma plasma cells: toward antibody panel specifications for MRD detection in multiple myeloma, cytometry B Clin","volume":"90","author":"Flores-Montero","year":"2016","journal-title":"Cytom"},{"key":"10.1016\/j.mtbio.2026.103397_bib103","article-title":"Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma | Haematologica","volume":"89","author":"Moreau","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.mtbio.2026.103397_bib104","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.leukres.2016.03.003","article-title":"The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma","volume":"44","author":"Gonsalves","year":"2016","journal-title":"Leuk. Res."},{"key":"10.1016\/j.mtbio.2026.103397_bib105","doi-asserted-by":"crossref","first-page":"7599","DOI":"10.1158\/1078-0432.CCR-05-0523","article-title":"The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype","volume":"11","author":"Yaccoby","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103397_bib106","unstructured":"Biocolor company, Blyscan Sulfated Glycosaminoglycan Assay General Protocol, n.d."},{"key":"10.1016\/j.mtbio.2026.103397_bib107","first-page":"217","article-title":"Biochemical methods for the analysis of tissue-engineered cartilage","volume":"238","author":"Kafienah","year":"2004","journal-title":"Methods Mol. Biol."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426006423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426006423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:06:16Z","timestamp":1787025976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426006423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":107,"alternative-id":["S2590006426006423"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103397","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3D biomimetic microgel platform for multiple myeloma: Approaching tumor microenvironment on cell lines and patient-derived cells","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103397"}}